Learn more

FMC BIOPOLYMER AS

Overview
  • Total Patents
    157
  • GoodIP Patent Rank
    240,493
About

FMC BIOPOLYMER AS has a total of 157 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and medical technology are NYCOMED PHARMA AS, ROYER BIOMEDICAL INC and POLYPID LTD.

Patent filings per year

Chart showing FMC BIOPOLYMER ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gaserod Olav 34
#2 Dornish Michael 29
#3 Melvik Jan Egil 21
#4 Andersen Peder Oscar 19
#5 Larsen Christian Klein 17
#6 Dessen Arne 13
#7 Andersen Therese 13
#8 Onsoyen Edvar 12
#9 Skjak-Braek Gudmund 11
#10 Berge Astrid B 10

Latest patents

Publication Filing date Title
CA2662560A1 Oligonucleotide non-viral delivery systems
WO2007148197A2 Gastro-activated dietary fibers
BRPI0714386A2 hydrogel, bead, methods for producing a hydrogel or bead, for implanting an implantable medical bead or device and cells in a patient, for blocking blood vessels, and for forming a hydrogel, implantable medical device, drug release formulation, contrast or radioopaque material, and, embolic therapeutic composition
EP2029727A2 Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof.
WO2007123598A1 A foam and use thereof
BRPI0708429A2 method for forming a dry absorbent foam, dry absorbent foam, composite, use of a foam or composite, and methods for inhibiting cell proliferation, for attaching a composite to tissue, and for preventing tissue adhesion to adjacent tissue
US2007087038A1 Gelling compositions and methods
BRPI0613622A2 Medical device
US2008199914A1 Modified Alginates, Methods of Production and Use
CN101103047A Modified alginates, methods of production and use
BR122018068450B1 implantable device comprising alginate gel
US7790193B2 Use of alginate matrices to control cell growth
US7674837B2 Gelled biopolymer based foam
AU2003228156A1 Non-viral gene delivery system
CN1655826A Non-viral gene delivery system
CN101919827A Polysaccharide capsules and methods of preparation
CN102210700A Oral immunostimulation of mammals, birds, and reptiles from (1-4) linked beta-D-mannuronic acid
CN1596270A Process for the production of alginate having a high mannuronic acid-content
EP1460964A2 Oral immunostimulation of mammals, birds, fish and reptiles from (1-4) linked b -d-mannuronic acid
US6087342A Substrates having bound polysaccharides and bacterial nucleic acids